Multi-trait genome-wide association study identifies novel endometrial cancer risk loci that are associated with obesity or female testosterone levels

We have performed genetic correlation and Mendelian randomization analyses using publicly available genome-wide association study (GWAS) data to identify endometrial cancer risk factors. These and previously established risk factors of endometrial cancer were then included in a multi-trait Bayesian GWAS analysis to detect endometrial cancer susceptibility variants, identifying three novel loci (7q22.1, 8q24.3 and 16q12.2); two of which were replicated in an independent endometrial cancer GWAS dataset. These loci are hypothesized to affect endometrial cancer risk through altered sex-hormone levels or through effects on obesity. Consistent with this hypothesis, several genes with established roles in these pathways (CYP11B1, CYP3A7, IRX3 and IRX5) were prioritized as candidate endometrial cancer risk genes by interrogation of quantitative trait loci data and chromatin capture assays in endometrial cell lines. The findings of this study identify additional opportunities for hormone treatment and further support weight loss to reduce the risk of developing endometrial cancer.

[1]  F W MULSOW,et al.  Cancer incidence and mortality , 2019, Health at a Glance: Europe.

[2]  Jie He,et al.  Cancer incidence and mortality in China, 2015 , 2020, Journal of the National Cancer Center.

[3]  A. Jemal,et al.  Cancer Statistics, 2021 , 2021, CA: a cancer journal for clinicians.

[4]  Y. Bossé,et al.  Electronic Health Record-Based Genome-Wide Meta-Analysis and Mendelian Randomization Identify Metabolic and Phenotypic Consequences of Non-Alcoholic Fatty Liver Disease , 2020 .

[5]  Ross M. Fraser,et al.  Sex-dimorphic genetic effects and novel loci for fasting glucose and insulin variability , 2020, Nature Communications.

[6]  D. Evans,et al.  The proportion of endometrial tumours associated with Lynch syndrome (PETALS): A prospective cross-sectional study , 2020, PLoS medicine.

[7]  M. Beckmann,et al.  Mendelian randomization analyses suggest a role for cholesterol in the development of endometrial cancer , 2020, International journal of cancer.

[8]  Gonçalo Abecasis,et al.  Computationally efficient whole-genome regression for quantitative and binary traits , 2020, Nature Genetics.

[9]  M. Kanai,et al.  Large-scale genome-wide association study in a Japanese population identifies novel susceptibility loci across different diseases , 2020, Nature Genetics.

[10]  Zoltán Kutalik,et al.  bGWAS: an R package to perform Bayesian genome wide association studies , 2020, Bioinform..

[11]  M. McCarthy,et al.  Using human genetics to understand the disease impacts of testosterone in men and women , 2020, Nature Medicine.

[12]  E. Crosbie,et al.  Endometrial cancer prevention in high-risk women. , 2019, Best practice & research. Clinical obstetrics & gynaecology.

[13]  M. Rivas,et al.  Sex-specific genetic effects across biomarkers , 2019, bioRxiv.

[14]  Christopher D. Brown,et al.  The GTEx Consortium atlas of genetic regulatory effects across human tissues , 2019, Science.

[15]  A. Spurdle,et al.  Analysis of Promoter-Associated Chromatin Interactions Reveals Biologically Relevant Candidate Target Genes at Endometrial Cancer Risk Loci , 2019, bioRxiv.

[16]  Zemin Zhang,et al.  GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis , 2019, Nucleic Acids Res..

[17]  S. Astley,et al.  Breast cancer pathology and stage are better predicted by risk stratification models that include mammographic density and common genetic variants , 2019, Breast Cancer Research and Treatment.

[18]  Z. Zeng,et al.  Analysis of status and countermeasures of cancer incidence and mortality in China , 2019, Science China Life Sciences.

[19]  J. Erdmann,et al.  Qtlizer: comprehensive QTL annotation of GWAS results , 2018, Scientific Reports.

[20]  B. Stranger,et al.  Sex differences in the genetic architecture of obsessive–compulsive disorder , 2018, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[21]  David M. Evans,et al.  An atlas of genetic influences on osteoporosis in humans and mice , 2018, Nature Genetics.

[22]  E. Crosbie,et al.  Prevention Strategies in Endometrial Carcinoma , 2018, Current Oncology Reports.

[23]  G. Abecasis,et al.  Sex-specific and pleiotropic effects underlying kidney function identified from GWAS meta-analysis , 2018, bioRxiv.

[24]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[25]  P. Visscher,et al.  Genomics of 1 million parent lifespans implicates novel pathways and common diseases and distinguishes survival chances , 2019, eLife.

[26]  E. Crawford,et al.  Androgen-targeted therapy in men with prostate cancer: evolving practice and future considerations , 2018, Prostate Cancer and Prostatic Diseases.

[27]  Peter Kraft,et al.  Identification of nine new susceptibility loci for endometrial cancer , 2018, Nature Communications.

[28]  Ovidiu Lungu,et al.  Consolidation alters motor sequence-specific distributed representations , 2018, bioRxiv.

[29]  Jacques Ferlay,et al.  International Patterns and Trends in Endometrial Cancer Incidence, 1978-2013. , 2018, Journal of the National Cancer Institute.

[30]  Valeriia Haberland,et al.  The MR-Base platform supports systematic causal inference across the human phenome , 2018, eLife.

[31]  D. Kiel,et al.  Genetic Determinants of Circulating Estrogen Levels and Evidence of a Causal Effect of Estradiol on Bone Density in Men , 2018, The Journal of clinical endocrinology and metabolism.

[32]  Qingcheng Mao,et al.  Digging Deeper into CYP3A Testosterone Metabolism: Kinetic, Regioselectivity, and Stereoselectivity Differences between CYP3A4/5 and CYP3A7 , 2017, Drug Metabolism and Disposition.

[33]  Gary D Bader,et al.  Association analysis identifies 65 new breast cancer risk loci , 2017, Nature.

[34]  K. Reue,et al.  Genetic Basis for Sex Differences in Obesity and Lipid Metabolism. , 2017, Annual review of nutrition.

[35]  Aaron F. McDaid,et al.  Bayesian association scan reveals loci associated with human lifespan and linked biomarkers , 2017, Nature Communications.

[36]  P. Visscher,et al.  Causal associations between risk factors and common diseases inferred from GWAS summary data , 2017, bioRxiv.

[37]  T. Xiao,et al.  Complex Relationship between Obesity and the Fat Mass and Obesity Locus , 2017, International journal of biological sciences.

[38]  E. Demerath,et al.  Genomic analyses identify hundreds of variants associated with age at menarche and support a role for puberty timing in cancer risk , 2017, Nature Genetics.

[39]  E. Crosbie,et al.  Interventions for weight reduction in obesity to improve survival in women with endometrial cancer. , 2017, The Cochrane database of systematic reviews.

[40]  M. Beckmann,et al.  Genetic Risk Score Mendelian Randomization Shows that Obesity Measured as Body Mass Index, but not Waist:Hip Ratio, Is Causal for Endometrial Cancer , 2016, Cancer Epidemiology, Biomarkers & Prevention.

[41]  K. Kalland,et al.  Androgen receptor as potential therapeutic target in metastatic endometrial cancer , 2016, Oncotarget.

[42]  Hui Zhao,et al.  Five endometrial cancer risk loci identified through genome-wide association analysis , 2016, Nature Genetics.

[43]  M. Beckmann,et al.  CYP19A1 fine-mapping and Mendelian randomization: estradiol is causal for endometrial cancer , 2015, Endocrine-related cancer.

[44]  Manolis Kellis,et al.  FTO Obesity Variant Circuitry and Adipocyte Browning in Humans. , 2015, The New England journal of medicine.

[45]  J. Perry,et al.  Evidence of a Causal Association Between Insulinemia and Endometrial Cancer: A Mendelian Randomization Analysis , 2015, Journal of the National Cancer Institute.

[46]  T. Spector,et al.  Genome-wide association study with 1000 genomes imputation identifies signals for nine sex hormone-related phenotypes , 2015, European Journal of Human Genetics.

[47]  P. Elliott,et al.  UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age , 2015, PLoS medicine.

[48]  Yutao Yang,et al.  MEIS1 functions as a potential AR negative regulator. , 2014, Experimental cell research.

[49]  Cesare Furlanello,et al.  A promoter-level mammalian expression atlas , 2015 .

[50]  N. Cox,et al.  Obesity-associated variants within FTO form long-range functional connections with IRX3 , 2014, Nature.

[51]  M. Daly,et al.  LD Score regression distinguishes confounding from polygenicity in genome-wide association studies , 2014, Nature Genetics.

[52]  M. Pike,et al.  Type I and II endometrial cancers: have they different risk factors? , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[53]  Ross M. Fraser,et al.  Sex-stratified Genome-wide Association Studies Including 270,000 Individuals Show Sexual Dimorphism in Genetic Loci for Anthropometric Traits , 2013, PLoS genetics.

[54]  P. Visscher,et al.  Conditional and joint multiple-SNP analysis of GWAS summary statistics identifies additional variants influencing complex traits , 2012, Nature Genetics.

[55]  M. Beckmann,et al.  Genome-wide association study identifies a common variant associated with risk of endometrial cancer , 2011, Nature Genetics.

[56]  P. Visscher,et al.  GCTA: a tool for genome-wide complex trait analysis. , 2011, American journal of human genetics.

[57]  Yun Li,et al.  METAL: fast and efficient meta-analysis of genomewide association scans , 2010, Bioinform..

[58]  Mikael Bodén,et al.  MEME Suite: tools for motif discovery and searching , 2009, Nucleic Acids Res..

[59]  Y. Hayashizaki,et al.  FOXP1 is an androgen-responsive transcription factor that negatively regulates androgen receptor signaling in prostate cancer cells. , 2008, Biochemical and biophysical research communications.